S
Sara Erridge
Researcher at Western General Hospital
Publications - 65
Citations - 4317
Sara Erridge is an academic researcher from Western General Hospital. The author has contributed to research in topics: Temozolomide & Lung cancer. The author has an hindex of 22, co-authored 61 publications receiving 3672 citations. Previous affiliations of Sara Erridge include University of Edinburgh.
Papers
More filters
Journal ArticleDOI
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp,Roger Stupp,Monika E. Hegi,Thierry Gorlia,Sara Erridge,James Perry,Yong-Kil Hong,Kenneth Aldape,Benoit Lhermitte,Torsten Pietsch,Danica Grujicic,Joachim P. Steinbach,Wolfgang Wick,Rafal Tarnawski,Do-Hyun Nam,Peter Hau,Astrid Weyerbrock,Martin J B Taphoorn,Chiung-Chyi Shen,Nalini Rao,László Thurzó,Ulrich Herrlinger,Tejpal Gupta,Rolf-Dieter Kortmann,Krystyna Adamska,Catherine McBain,Alba A. Brandes,Joerg C. Tonn,Oliver Schnell,Thomas Wiegel,Chae-Yong Kim,Louis B. Nabors,David A. Reardon,Martin J. van den Bent,Christine Hicking,Andriy Markivskyy,Martin Picard,Michael Weller +37 more
TL;DR: This multicentre, open-label, phase 3 study investigated the efficacy of cilengitide in patients from 146 study sites in 25 countries and found none of the predefined clinical subgroups showed a benefit.
Journal ArticleDOI
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
Mark R. Gilbert,Meihua Wang,Kenneth Aldape,Roger Stupp,Monika E. Hegi,Kurt A. Jaeckle,Terri S. Armstrong,Terri S. Armstrong,Jeffrey S. Wefel,Minhee Won,Deborah T. Blumenthal,Anita Mahajan,Christopher J. Schultz,Sara Erridge,Brigitta G. Baumert,Kristen I. Hopkins,Tzahala Tzuk-Shina,Paul D. Brown,Arnab Chakravarti,Walter J. Curran,Minesh P. Mehta +20 more
TL;DR: This study did not demonstrate improved efficacy for DD temozolomide for newly diagnosed GBM, regardless of methylation status, but it did confirm the prognostic significance of MGMT methylation.
Journal ArticleDOI
Current concepts and management of glioblastoma.
Matthias Preusser,Sandrine de Ribaupierre,Adelheid Wöhrer,Sara Erridge,Monika E. Hegi,Michael Weller,Roger Stupp +6 more
TL;DR: This review covers major aspects of care of glioblastoma patients with a focus on the management of common symptoms and complications, and aims to provide a guide for clinicians confronted with gliobeastoma patients in their everyday practice.
Journal ArticleDOI
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
Martin J. van den Bent,Brigitta G. Baumert,Sara Erridge,Michael A. Vogelbaum,Michael A. Vogelbaum,Anna K. Nowak,Anna K. Nowak,Anna K. Nowak,Marc Sanson,Alba A. Brandes,Paul Clement,Jean Francais Baurain,Warren P. Mason,Helen Wheeler,Helen Wheeler,Olivier Chinot,Sanjeev Gill,Matthew E. Griffin,David Brachman,Walter Taal,Roberta Rudà,Michael Weller,Catherine McBain,Jaap C. Reijneveld,Jaap C. Reijneveld,Roelien H. Enting,Damien C. Weber,Thierry Lesimple,Susan Clenton,Anja Gijtenbeek,Sarah Pascoe,Ulrich Herrlinger,Peter Hau,Frédéric Dhermain,Irene van Heuvel,Roger Stupp,Kenneth Aldape,Robert B. Jenkins,Hendrikus J. Dubbink,Winand N.M. Dinjens,Pieter Wesseling,Pieter Wesseling,Sarah Nuyens,Vassilis Golfinopoulos,Thierry Gorlia,Wolfgang Wick,Johan M. Kros +46 more
TL;DR: Adjuvant temozolomide chemotherapy was associated with a significant survival benefit in patients with newly diagnosed non-co-deleted anaplastic glioma, and the null hypothesis of no efficacy was tested.
Journal ArticleDOI
ESTRO-ACROP guideline "target delineation of glioblastomas"
Maximilian Niyazi,Michael Brada,Anthony J. Chalmers,Stephanie E. Combs,Sara Erridge,Alba Fiorentino,Anca L. Grosu,Frank J. Lagerwaard,Giuseppe Minniti,René-Olivier Mirimanoff,Umberto Ricardi,Susan C Short,Damien C. Weber,Claus Belka +13 more
TL;DR: This guideline aims to develop a joint European consensus on the delineation of the clinical target volume in patients with a glioblastoma (GBM) using isotropic margins without the need to cone down.